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Objective: Preoperative pulmonary venous obstruction has been reported to be a risk
factor negatively impacting survival in total anomalous pulmonary venous connec-
tion. We examined lung tissue from total anomalous pulmonary venous connection
patients with pulmonary venous obstruction and demonstrated hypoplasia of small
pulmonary arteries to elucidate the mechanism underlying the poor outcome.
Methods: Ten total anomalous pulmonary venous connection patients with preop-
erative pulmonary venous obstruction between the ages of 2 days and 10 months
were studied. As histological parameters, we assessed the size of small pulmonary
arteries in relation to the size of accompanying bronchioles to identify small
pulmonary artery underdevelopment. Other parameters, such as the radial alveolar
count, which reflects alveolar maturity, intimal lesions, lymphangiectasia, and the
medial thickness of small pulmonary arteries and small pulmonary veins, were also
examined. As a control group, we examined 24 autopsy cases with no congenital
heart or pulmonary disease.
Results: When the radius of the accompanying bronchiole was 100 m, the radius
of small pulmonary artery in the control group was found to enlarge for the first 2
months and then remain stable at approximately 80 m from 2 to 10 months. In total
anomalous pulmonary venous connection with preoperative pulmonary venous
obstruction, the radius was significantly lower than in the control (47.0  21.8 m
versus 75.9  9.8 m, P  .001), and the difference between dead and surviving
patients was significant at P  .001 (33.0  14.6 m versus 68.2  9.2 m).
Examination of the alveoli yielded an radial alveolar count of 4.6  1.5 in the
control group and 4.4  0.8 in the total anomalous pulmonary venous connection
patients, and the difference was not significant (P  .71).
Conclusions: The small pulmonary arteries of total anomalous pulmonary venous
connection patients with preoperative pulmonary venous obstruction were under-
developed compared with controls but their alveolae were not hypoplastic. These
results suggested that the small pulmonary artery hypoplasia may be responsible for
the poor outcome of these patients.
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Total anomalous pulmonary venous connec-tion (TAPVC) is a rare, life-threatening con-genital cardiac anomaly, and without surgi-cal repair, the majority of patients die withinthe first year of life.1 There have been re-markable improvements in operative sur-
vival over the years and the surgical mortality reported has
ranged from 0% to 11%.2-7 However, postoperative prob-
lems such as recurrent pulmonary vein obstruction (PVO),
pulmonary hypertensive (PH) crisis, and low cardiac output
may still occur, and they can be fatal.3-7
TAPVC is classically subdivided into 4 distinct catego-
ries according to the anatomy of the drainage of the pulmo-
nary veins, and each category can be subdivided into ob-
structed and nonobstructed types. Obstructed-type TAPVC
is defined as an obstruction of either pulmonary vein, ver-
tical veins, or descending veins at the time of diagnosis and
is called “preoperative (primary) PVO” to differentiate it
from postoperative (secondary) PVO following repair or
intervention. Primary PVO causes elevation of pulmonary
artery pressure and usually presents as a neonatal emer-
gency, and it is reported to be a risk factor that negatively
impacts early and late survival, even after repair.4,5,7
Based on the above, we collected lung specimens taken
from obstructed-type TAPVC patients (who account for
approximately 30% of all TAPVC patients1,4,7) and inves-
tigated various histological characteristics to determine the
cause of the poor outcome in these patients. We particularly
examined them for the presence of hypoplasia of small
pulmonary arteries (SPAs; pulmonary arteries with a mus-
cular coat observed in biopsy specimens, with diameters
ranging from 100 to 500 m). Although various types of
pulmonary vascular lesions have been reported in TAPVC,
few reports have discussed hypoplasia or underdevelopment
of SPAs. One reason for this is that there is as yet no clear
definition of hypoplasia of SPAs. Noting the fact that bron-
chioles always accompany SPAs in lung specimens,8,9 we
describe a method of comparing the degree of development
of SPA among patients.
Materials and Methods
Ten infants with obstructed-type TAPVC, ranging in age from 2
days to 10 months (mean age, 92.9 days) at the time of biopsy or
autopsy, between 1996 and 2002, were studied. The study was
approved by the institutional review board, and informed consent
was obtained from the infants’ relatives. Excluded from analysis
were infants with associated complex lesions, such as single ven-
tricle or hypoplastic left ventricle. All patients had preoperative
PVO, which is considered to be present when (1) the gradient
between the pulmonary artery wedge and mean left atrial pressure
is 5 mm Hg by cardiac catheterization; (2) there is angiographic
evidence or intraoperative observation of a localized or segmental
reduction in pulmonary vein (or vertical vein or descending vein)
diameter by 50%; or (3) there is a mean gradient of 5 mm Hg
across the narrowed pulmonary vein as measured by Doppler
echocardiography.6 Biopsies were performed during TAPVC re-
pair in 5 patients. The lung tissue in the 5 other patients was
obtained at autopsy. All biopsy and autopsy tissue was taken from
the lobe in which the pulmonary blood drainage was obstructed.
Breakdown by disease type was as follows: supracardiac type
(Daring’s classification), 3; cardiac type, 2; infracardiac type, 5;
and mixed type, 0. The clinical profiles and outcomes of these
patients are summarized in Table 1.
As a control group, we examined tissues from 24 autopsy cases
with no congenital heart or pulmonary disease in which death
occurred from 1 day to 10 months of age (mean age: 80.5 days).
All control group infants had been born full-term. Ten of the
infants had died from infection, 5 from accidents, 3 from brain
hemorrhage, 3 from tumors, 2 from metabolic disorders, and 1
from intussusception.
Tissue Preparation
One block from each lung was fixed in 10% formalin, and paraffin
histologic sections were prepared. In each case, 30 step-sections at
50-m intervals were prepared. Elastica-Goldner staining was
performed.10 We assessed the following: (1) severity of intimal
lesions; (2) radius and medial thickness of SPAs and small pul-
monary veins (SPVs; pulmonary veins with a muscular coat ob-
served in biopsy specimens, with diameters ranging from approx-
imately 100 to 500 m); (3) radius of bronchioles and the radius
of SPAs accompanying the bronchioles (supernumeral arteries9
that did not run parallel with the bronchioles were excluded); (4)
RAC, which reflects lung maturity; and (5) the presence of lym-
phangiectasia.
Measurements
The medial thickness (DA) and radius (RA) of SPAs and SPVs
were measured using a previously reported morphohistometric
method.11 All SPAs were scanned with a digitizing camera (Olym-
pus PDMC/OL; Olympus, Tokyo, Japan), and the images were fed
into a Macintosh computer (PowerMac G4; Apple Japan Inc,
Tokyo, Japan). All the morphohistological measurements below
were performed using NIH image version 1.53 software (National
Institutes of Health, Bethesda, Md). Assuming uniform thickness,
DA and RA were calculated from the length of internal elastic
membrane (LA) and the area of the media (SA) by using the
following equation (Figure 1, A):
DA  {(LA2  4SA)1/2  LA}/2
RA  SA/{(LA2  4SA)1/2  LA}
The values of RA and DA were obtained from at least 20
samples from each patient and plotted on a logarithmic coordinate
system. Linear regressions of RA and DA were performed, and the
DA value at R  100 m (DR100m) was calculated so that
medial thickness could be compared.
The radius of bronchioles (RB) accompanying preacinar SPAs
was measured by modifying the technique of Berend and col-
leagues.12 Because bronchioles are sometimes distorted and con-
tracted in prepared specimens, the radius was calculated in our
study in the state in which the internal basement membrane was
extended in the form of a circle to avoid errors resulting from
distortion or contraction. The length of the basement membrane of
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the bronchiole (LB) was measured (Figure 1, A), and RB was
calculated by using the following equation:
RB  LB/2
The values of RA and RB were obtained in at least 20 pairs from
each tissue and plotted on a logarithmic coordinate system (Figure
2). Linear regressions of these 2 radii were performed, and the
SPA radius at an accompanying bronchiolar radius of 100 m was
calculated so that the radius of SPA in relation to that of the
accompanying bronchiole could be compared among patients.
Only transversely cut airways and SPAs were used for the mea-
surements above. In addition, to avoid the influence of ramifica-
tions, we excluded pairs in which arterial and bronchial ramifica-
tions occurred in different planes (in such situations, a single
bronchus might be accompanied by 2 arteries).
RACs were made according to the description of Emery and
Mithal13 with the modifications of Cooney and Thurbeck.14,15 This
procedure measures the number of airways in the secondary lobule
and is suitable for material available in a retrospective study. The
mean RAC in each patient was calculated from all suitable areas in
all available sections. Only uninflated lungs were used for the
assessment in our study group.
The severity of the intimal lesions was evaluated by using the
Heath-Edwards (HE) classification16 and the index of pulmonary
vascular disease (IPVD) as described in our previous report.11 The
IPVD was determined by classifying the pulmonary vascular inti-
mal lesions of SPAs into 4 grades, with ratings of 1 to 4 assigned
to each artery, and the mean rating was calculated for each patient.
The ratings were based on the following pathologic findings: A
rating of 1: no intimal lesions; 2: cellular proliferation of the
intima; 3: fibrous thickening of the intima; and 4: destruction of the
media.
We also examined all the slides we had prepared for the
presence of lymphangiectasia. Lymphangiectasia is a condition in
which lymph vessels are excessively dilated, giving rise to clusters
of grossly distended lymph vessels in tissue.17
Statistics
All values are reported as means  standard deviation. Because
the standard value calculated from the 24 control patients varied
with age, statistical comparisons among groups were made by
analysis of covariance using age as a covariant factor. The regres-
sion equations derived from the correlation between age and
histologic parameters are used to describe their relationship, and
5% and 95% confidence limits were calculated. A P value of less
than .05 was considered significant. All statistical analyses were
performed using Statview version 5.0J software.
Results
Radii of SPAs When Accompanying Bronchiolar
Radius  100 m
The radius of SPA was approximately 60 m at birth,
increased for the first 2 months, and then remained stable at
about 80 m from 2 to 10 months. The radius of SPA in
TAPVC patients with preoperative PVO was 47.0  21.8
m, and significantly smaller than in the controls (75.9 
9.8 m, P  .001). The difference between dead and
surviving patients was significant at P  .001 (33.0  14.6
m versus 68.2  9.2 m; Figure 3). The smallest radius
was in patient 4, who underwent emergency surgery at 2
days of age because of severe hypoxia and developed severe
PH that failed to respond to any therapy before death at 0
postoperative day (Figure 2, B).
RAC
The RAC was 4.6  1.5 in the control group, and it tended
to increase with age. In the TAPVC patients, the RAC was
4.4  0.8 and not significantly different from the value in
the control group (P  .71). The difference between the 2
TAPVC groups (dead versus surviving, 4.1 0.8 versus 4.9
 0.8; P .19) was not significant. The RAC in all TAPVC
patients was within the 5% to 95% confidence limits of the
control group (Figure 4).
Intimal Lesions
The results for intimal lesions and lymphangiectasia are
shown in Table 1. All the IPVD values for intimal lesions in
TABLE 1. Patient characteristics
Patient
no.
Gestational
age (wk)
Age at
operation
(d)
BW at
operation
(kg)
Anotomic
type Biopsy or autopsy HE IPVD Lym. Outcome and cause of death
1 36 12 2.9 TAPVC[I b] autopsy 1 1.0  Dead at 0POD (PHC, AVF)
2 40 18 2.6 TAPVC(II) autopsy 1 1.0  Dead at 5POD (PHC)
4 36 2 3 TAPVC (II b) autopsy 1 1.0  Dead at 0POD (PHC, AVF)
5 40 14 3.1 TAPVC(I b) autopsy 1 1.0  Dead at 14POD (PPH)
6 39 45 3.3 TAPVC(II) Biopsy (left lung) 2 1.2  Dead at 30POD (PPH, PVS)
9 38 284 6.2 TAPVC(II) Biopsy (left lung) 3 1.8  Dead at 28POD (PPH, PVS)
3 40 43 3.1 TAPVC(II) Biopsy (left lung) 1 1.0  Alive (5 y follow-up)
7 38 301 7.8 TAPVC(II) Biopsy (left lung) 3 1.7  Alive (5 y follow-up)
8 27 180 4.3 TAPVC(I b) Biopsy (right lung) 3 1.8  Alive (6 y follow-up)
10 36 30 3.2 TAPVC(II) Biopsy (right lung) 1 1.2  Alive (4 y follow-up)
PHC, Pulmonary hypertension crisis; AVF, acute ventricular failure; PPH, persistent pulmonary hypertension; HE, Edwards classification; IPVD, intrapul-
monary vascular disease score; Lym., lymphangiectosis.
Surgery for Congenital Heart Disease Maeda et al
450 The Journal of Thoracic and Cardiovascular Surgery ● February 2004
CH
D
the control patients were 1.0, whereas the mean IPVD score
in TAPVC with PVO was 1.3  0.4 (significantly higher
than in the control patients at P  .001). In 5 of the 10
patients, the scores were 1.0, which means that there were
no intimal lesions in the SPAs. Three infants whose IPVD
scores were greater than 1.0 survived the operation. The
difference between the dead and surviving patients was not
significant (1.2  0.3 versus 1.4  0.4; P  .059). Accord-
ing to HE classification, there were 6 grade 1 patients, 1
grade 2 patient, 3 grade 3 patients, and no patients at grade
4 or more. It is noteworthy that 2 of the patients with HE
grade 3 survived.
Lymphangiectasia
Lymphangiectasia was not detected in any of the control
patients but was present in 4 of the 6 dead TAPVC patients
(66.6%) and in 1 of the 4 surviving TAPVC patients (25%)
(control versus TAPVC patients, P  .01; dead versus
surviving patients, P  .19, NS). Interstitial emphysema
was seen in all of the patients with lymphangiectasia.
Medial Thicknesses of SPAs
In the control group, medial thicknesses ranged from 4.2 to
13.1 m (7.4  2.2 m), and in relationship to age, hyper-
trophy of the media was regressed for the first month after
Figure 1. A, A normal bronchiole (radius of approximately 100 m) and an accompanying small pulmonary artery.
Three measured parameters are shown above: SA, area of media of SPA; LA, length of internal elastic membrane
of SPA; LB, length of basement membrane of bronchioles. B, A hypoplastic small pulmonary artery accompanying
a bronchiole (radius of approximately 100 m) in TAPVC patient 3. The radius of the accompanying SPA is as small
as 30% of that of the accompanying bronchiole.
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birth and remained almost stable at approximately 6 to 8
m. By contrast, the medial thickness of the SPAs in the 10
TAPVC patients with preoperative PVO was 8.7 to 16.9 m
(11.7  2.5 m, significantly thicker at P  .001). The
difference in medial thickness of the SPAs between the dead
patients and surviving patients was not significant (12.2 
2.8 m versus 11.1 2.3 m; P .60). There was no clear
age difference between the TAPVC groups (Figure 5, A).
Medial Thickness of SPVs
The medial thickness of SPVs in the control group was 0.7
to 4.0 m (2.2  1.0 m) and remained constant at approx-
imately 2 to 3 m after birth. Medial thickness of the SPVs
in the TAPVC patients was 1.1 to 7.8 m (4.5  2.3 m),
significantly greater than in the control group (P  .001).
There was a slight difference between the dead and surviv-
ing patients with medial thickness in the surviving patients
Figure 2. There was a significant correlation between bronchiolar radii and the radii of accompanying small
pulmonary arteries on a logarithmic coordinate system. The radius of small pulmonary arteries at a bronchiolar
radius of 100 m was calculated based on linear regression and used for comparative analysis.
Figure 3. The radii of small pulmonary arteries at a bronchiolar radius of 100 m are plotted against age in 24
control patients and 10 TAPVC patients. The logarithmic curve fit with 5% and 95% confidence limits is also shown.
A significant difference between control patients and TAPVC with preoperative PVO patients was found, and the
radii in the deceased patients were significantly smaller than in the surviving patients.
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being thicker than that in the dead patients (6.4  1.3 m
versus 3.3  1.8 m; P  .039; Figure 5, B).
Discussion and Conclusion
In spite of the great improvements in preventing pulmonary
hypertension, almost all deaths after repair of TAPVC are
associated with eventual pulmonary hypertensive events.3-7
Persistent PH or PH crisis after repair of other congenital
heart anomaly has been reported to be caused by plexogenic
arteriopathy, especially by irreversible intimal lesions.
However, as previously reported,17,18 the intimal lesion in
TAPVC is not particularly severe, and the pathogenesis of
PH events related to poor outcomes does not appear to be
solely plexogenic arteriopathy.
Several published reports have discussed the problem of
underdevelopment of the pulmonary vasculature or of re-
duction in the number of lung vessels. This problem was
first reported in primary plexogenic arteriopathy19 and sub-
sequently in other types of congenital heart disease.20,21
However, counting SPAs has been questioned, because the
number of SPAs was demonstrated not to be decreased or to
even be increased in other studies.22,23 Mooi and Wagen-
voort24 stated that the controversy regarding underdevelop-
ment or disappearance of lung vessels centers to a large
extent on methodology. One reason, they say, is that almost
all histological studies in which a decrease in the number of
lung vessels has been reported were based on lungs sub-
jected to vessel filling at a pressure of 100 cm of water.
However, such high pressures produce unpredictable results
and may sometimes cause such excessive dilatation of blood
vessels that small vessels become unidentifiable and, hence,
are not counted.24 Another reason is the size of the field of
lung tissue used for quantitative analysis being relatively
small, as pulmonary arteries are not distributed evenly
throughout the lung tissue.23,24 To eliminate these influ-
ences, in our study (1) only uninflated lungs not injected
under pressure were used, and (2) we calculated the ratio
between SPAs and accompanying bronchiole in at least 20
pairs to compare patients and demonstrate hypoplasia.
The relationship between bronchial diameter and arterial
diameter in normal human lungs was first reported by Be-
rend and colleagues in 1979.12 They measured 8 lungs from
4 adult patients without lung disease and established an
average ratio between internal bronchial and external arte-
rial diameter of 0.62. However, they included the adventitia
in the latter diameter, which is rather unusual and produces
variable results.25 Moreover, bronchioles contract after
death,25 and the degree of constriction needs to be corrected
for. We therefore measured the length of the basement
membrane and estimated the diameter of bronchioles in a
state of complete extension.
Our results show that in obstructed-type TAPVC pa-
tients, SPAs are reduced in size in comparison with accom-
panying bronchioles. In the control group, the radius of the
SPAs when the accompanying bronchiole had a radius of
100 m was approximately 60 m at birth and gradually
increased to 80 m by 2 months of age. By contrast, in the
dead patients, the smallest diameter was 14.6 m and the
largest was 33.0 m. It seems reasonable to assume that
underdevelopment of the SPAs results in increased pulmo-
nary vascular resistance despite the presence of only mild
intimal lesions. The pressure in the pulmonary arteries then
Figure 4. Correlation of radial alveolar counts with chronological age in controls and TAPVC patients. The
logarithmic curve fit with 5% and 95% confidence limits is also shown.
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increases, and the media of SPA hypertrophy proportion-
ately. Under these circumstances, pulmonary hypertension
persists even after surgical repair, and PH crisis with right
ventricular failure can easily occur in response to minor
stimuli.
The pathogenesis of the reduced size of SPAs is not
understood. Some studies have shown that banding the
pulmonary artery in the newborn pig leads to the develop-
ment of fewer and smaller intra-acinar arteries than nor-
mal,26 and the SPAs of patients with pulmonary atresia are
said to be smaller than normal.27,28 Although blood flow in
fetuses with TAPVC and preoperative PVO has not yet been
investigated, it can be assumed that pulmonary blood flow is
inhibited by the increased pulmonary venous pressure
caused by venous obstruction. In this study we were able to
obtain tissue from obstructed-type TAPVC patients and
normal controls without any PVO. Further investigation,
including unobstructed TAPVC patients, is needed to clar-
ify the role of PVO in the pathogenesis of SPA hypoplasia.
The RAC is said to reflect the degree of alveolar hyp-
oplasia or alveolar surface complexity, which is a significant
component in hypoplasia of the lung and parallels the lung
maturity.13,14,29 George and colleagues15 reported 10 infants
with congenital diaphragmatic hernia who died in the im-
mediate perinatal period; the RAC was reduced in every
patient, possibly due to persistent lung compression during
Figure 5. A, Medial thickness of small pulmonary arteries (DR100m), plotted against age in 10 TAPVC patients and
24 control patients. B, Medial thickness of small pulmonary veins (DR100m), plotted against age in the TAPVC and
control patients.
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the fetal period. In our study, however, the RAC was not
significantly reduced in TAPVC patients, and all values
were within the 5% to 95% confidence limits of the control
curve. The mechanism of the vascular hypoplasia in
TAPVC is different from the mechanism of the alveolar
immaturity. Lymphangiectasia has been reported in approx-
imately 30% of all TAPVC patients,17 and in the present
study it was found in 50% of the patients. This was probably
because our group was limited to obstructed TAPVC pa-
tients. In contrast to the rate of 25% in the surviving
TAPVC patients, 66% of dead patients showed lymphangi-
ectasia, which may be related to hypoplasia of SPAs and
poor outcome.
In the clinical setting, it may be very difficult to detect
hypoplasia of SPAs by routine diagnostic procedures. The
degree of hypoplasia in which patients can survive opera-
tions is unclear. As a possible treatment, patent ASDs may
also mitigate PH events in severe hypoplasia. As a means of
facilitating catheter access and balloon dilatation for inter-
vention in secondary PVO,3 electively leaving a small ASD
at the time of repair might has recently come into favor.
This may also facilitate the RL shunt and decrease PA
pressure in PH crisis. Once there is no further evidence of
PH events or postoperative PVO, the ASD can be closed by
transcatheter techniques.
There were limitations to this study. It was a retrospec-
tive study, and the number of patients was limited. The
series of patients does not represent a random sample of
patients who underwent TAPVC repair during the study
period. As might be expected, autopsy cases are overrepre-
sented in our series. Because the study group was limited to
obstructed-type TAPVC, no comparisons between obstruct-
ed- and unobstructed-type TAPVC were made in this study.
However, our results suggest that SPA hypoplasia is present
at least in obstructed-type TAPVC, and the degree of hyp-
oplasia may be related to an unfavorable outcome. Appli-
cation of this method may allow other problems associated
with poor mortality in congenital heart disease to be solved.
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